v3.26.1
Balance Sheet Details (Tables)
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Other Current Assets and Prepaid Expenses
Other Current Assets and Prepaid Expenses consist of (in thousands):
March 31, 2026December 31, 2025
Prepaid clinical and related costs$717 $2,064 
VAT receivable354 333 
Research grant receivable— 3,789 
Other1,059 1,200 
Total$2,130 $7,386 
Schedule of Accounts Payable and Accrued Expenses
Accounts Payable consist of (in thousands):
March 31, 2026December 31, 2025
Clinical costs$10,513 $9,493 
Legal and audit costs104 262 
Other394 383 
Total$11,011 $10,138 
Accrued Expenses consist of (in thousands):
March 31, 2026December 31, 2025
Accrued clinical and related costs$20,193 $16,102 
Accrued legal and audit costs516 137 
Accrued compensation880 2,168 
Accrued other843 238 
Total$22,432 $18,645 
Schedule of Other Current Liabilities
Other Current Liabilities consist of (in thousands):
March 31, 2026December 31, 2025
Lease liabilities$275 $470 
SARs liability2,710 809 
Stock Options issued subject to shares available1,123 — 
Other812 556 
Total$4,920 $1,835